EH-Domain Containing 2 (EHD2) (Middle Region) Peptid
EHD2
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle EHD2 Produkte
- EHD2 (EH-Domain Containing 2 (EHD2))
- Protein Region
- Middle Region
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Sequenz
- HMGPFVERGP DEAMEDGEEG SDDEAEWVVT KDKSKYDEIF YNLAPADGKL
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-EHD2 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
EH-Domain Containing 2 (EHD2) peptide
EHD2 Reaktivität: Human, Maus, Ratte, Rind (Kuh), Hund Wirt: Synthetic BP, Imm
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- EHD2 (EH-Domain Containing 2 (EHD2))
- Hintergrund
-
This gene encodes a member of the EH domain-containing protein family. These proteins are characterized by a C-terminal EF-hand domain, a nucleotide-binding consensus site at the N terminus and a bipartite nuclear localization signal. The encoded protein interacts with the actin cytoskeleton through an N-terminal domain and also binds to an EH domain-binding protein through the C-terminal EH domain. This interaction appears to connect clathrin-dependent endocytosis to actin, suggesting that this gene product participates in the endocytic pathway.
Alias Symbols: PAST2
Protein Size: 543 - Gen-ID
- 30846
- NCBI Accession
- NM_014601, NP_055416
- UniProt
- Q9NZN4
-
Sie sind hier:
